In view of the above and to obtain a histology-independent miRNA expression signature to differentiate glioblastoma from anaplastic astrocytoma tumors, we have analyzed the expression of 756 miRNAs by ...
Incidence of non-canonical IDH mutations and IDH co-mutations in a multicenter prospective study of patients with glioma.
The FDA has approved Voranigo to treat certain patients with grade 2 astrocytoma or oligodendroglioma with select mutations, following surgery. The Food and Drug Administration (FDA) has approved ...
Role of cranial radiotherapy for childhood T-cell acute lymphoblastic leukemia with high WBC count and good response to prednisone. Associazione Italiana Ematologia Oncologia Pediatrica and the Berlin ...
Q: Who should I consult when I have symptoms like memory loss, headaches and seizures? A: These symptoms can be seen in many disorders that affect the brain, hence you should first consult your ...
Please provide your email address to receive an email when new articles are posted on . The FDA approved vorasidenib for certain patients with astrocytoma or oligodendroglioma. The indication applies ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results